Abcellera Biologics Inc. · NASDAQ:ABCL

Booth Andrew exercised options for 250,000 Abcellera Biologics Inc. shares (Form 4)

Traded Jun 3, 2026 · Filed Jun 3, 2026

On Jun 3, 2026, Booth Andrew (Chief Financial Officer) exercised options for 250,000 Abcellera Biologics Inc. shares at US$0.19 for US$47,500, leaving 445,600 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
250,000 shares
Price
US$0.19
Value
US$47,500
Holding after
445,600 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 3, 2026Common SharesOption exercise250,000US$0.19445,600Direct

Source

View original at SEC

Related